Utilization of #COVID19 Tx & clinical outcomes among patients w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera et al. @CD_AACR https://t.co/enSLlL2TPt #AACRCovid #COVID19nCancer Fig2 Heatmap of selected clinical
Hydroxychloroquine + any other drug assoc w/ incr mortality --> Utilization of #COVID19 Tx & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera et al. @CD_AACR https://t.co/en
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/enSLlL2TPt #AACRCov
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
#COVID19 treatments & clinical outcomes among patients with cancer: #CCC19 cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/YvlJ0iMCVM #AACRCovid #COVID19nCancer n=2186 https://t.co/FO2nAvb1Gz
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
@NicoleKuderer @ADesaiMD @PGrivasMDPhD
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/v7lINKLnZi #AACRCov
RT @PGrivasMDPhD: Thanks @ZiadBakouny @ADesaiMD @arkhaki @JessicaHawleyMD @ArielleElkrief @rubinstein_md &other early career rising superst…
RT @ZiadBakouny: Want to interactively explore #COVID19 and Cancer data yourself and try to glean new insights? Check out the @COVID19nCCC…
RT @PGrivasMDPhD: Thanks @ZiadBakouny @ADesaiMD @arkhaki @JessicaHawleyMD @ArielleElkrief @rubinstein_md &other early career rising superst…
RT @ZiadBakouny: Want to interactively explore #COVID19 and Cancer data yourself and try to glean new insights? Check out the @COVID19nCCC…
RT @arkhaki: @OncoAlert: This is exciting! An interactive tool to explore data from @COVID19nCCC #CCC19 Excellent work by @ZiadBakouny to…
@OncoAlert: This is exciting! An interactive tool to explore data from @COVID19nCCC #CCC19 Excellent work by @ZiadBakouny to build this #Rshiny app
RT @PGrivasMDPhD: Thanks @ZiadBakouny @ADesaiMD @arkhaki @JessicaHawleyMD @ArielleElkrief @rubinstein_md &other early career rising superst…
RT @PGrivasMDPhD: Thanks @ZiadBakouny @ADesaiMD @arkhaki @JessicaHawleyMD @ArielleElkrief @rubinstein_md &other early career rising superst…
RT @PGrivasMDPhD: Thanks @ZiadBakouny @ADesaiMD @arkhaki @JessicaHawleyMD @ArielleElkrief @rubinstein_md &other early career rising superst…
RT @PGrivasMDPhD: Thanks @ZiadBakouny @ADesaiMD @arkhaki @JessicaHawleyMD @ArielleElkrief @rubinstein_md &other early career rising superst…
Thanks @ZiadBakouny @ADesaiMD @arkhaki @JessicaHawleyMD @ArielleElkrief @rubinstein_md &other early career rising superstars ⭐️ for supporting @COVID19nCCC @hemoncwarner @DrChoueiri @GlopesMd @mtmdphd @peters_solange @corrie_painter @DrDimpyShah @brian
RT @ZiadBakouny: Want to interactively explore #COVID19 and Cancer data yourself and try to glean new insights? Check out the @COVID19nCCC…
RT @ZiadBakouny: Want to interactively explore #COVID19 and Cancer data yourself and try to glean new insights? Check out the @COVID19nCCC…
RT @ZiadBakouny: Want to interactively explore #COVID19 and Cancer data yourself and try to glean new insights? Check out the @COVID19nCCC…
RT @ZiadBakouny: Want to interactively explore #COVID19 and Cancer data yourself and try to glean new insights? Check out the @COVID19nCCC…
RT @ZiadBakouny: Want to interactively explore #COVID19 and Cancer data yourself and try to glean new insights? Check out the @COVID19nCCC…
RT @ZiadBakouny: Want to interactively explore #COVID19 and Cancer data yourself and try to glean new insights? Check out the @COVID19nCCC…
RT @yekeduz_emre: Great job👏👏👏 https://t.co/vx3JLrDYaA
Great job👏👏👏
RT @ZiadBakouny: Want to interactively explore #COVID19 and Cancer data yourself and try to glean new insights? Check out the @COVID19nCCC…
RT @ZiadBakouny: Want to interactively explore #COVID19 and Cancer data yourself and try to glean new insights? Check out the @COVID19nCCC…
Want to interactively explore #COVID19 and Cancer data yourself and try to glean new insights? Check out the @COVID19nCCC #Rshiny app on the #CCC19 website: https://t.co/Zb1IRiHznV Data are based on our @CD_AACR paper: https://t.co/zdyBGqxeqj @hemoncwarn
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/enSLlL2TPt #AACRCov
@NicoleKuderer @PGrivasMDPhD @arkhaki @ADesaiMD #OncoAlert @OncoAlert
From the October issue: Utilization of #COVID19 treatments and clinical outcomes among patients with cancer— A COVID-19 and Cancer Consortium (#CCC19) cohort study. @COVID19nCCC @peters_solange @gary_lyman @hemoncwarner #COVID19nCancer https://t.co/q2RH
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study [Jul 22, 2020] Rivera et al. @CD_AACR https://t.co/v7lINKLnZi #CCC19 #AACRCovid #COVID19 #COVID19nCancer @COVID19nCCC
Utilization of #COVID19 Tx & clinical outcomes among patients w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera et al. @CD_AACR https://t.co/v7lINKLnZi #AACRCovid #COVID19nCancer Fig2 Heatmap of selected clinical
Hydroxychloroquine + any other drug assoc w/ incr mortality --> Utilization of #COVID19 Tx & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera et al. @CD_AACR https://t.co/v7
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/v7lINKLnZi #AACRCov
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/enSLlL2TPt #AACRCov
An observational study on COVID-19 treatments in cancer patients reported no statistically significant 30-day all-cause mortality benefit with hydroxychloroquine or high-dose corticosteroids alone or in combination; remdesivir showed potential benefit. ht
RT @imsmd: Thoughtful discussion of state of the COVID-19/cancer field by @CharuAggarwalMD: two of the studies are freely available https:/…
RT @imsmd: Thoughtful discussion of state of the COVID-19/cancer field by @CharuAggarwalMD: two of the studies are freely available https:/…
RT @imsmd: Thoughtful discussion of state of the COVID-19/cancer field by @CharuAggarwalMD: two of the studies are freely available https:/…
RT @imsmd: Thoughtful discussion of state of the COVID-19/cancer field by @CharuAggarwalMD: two of the studies are freely available https:/…
RT @imsmd: Thoughtful discussion of state of the COVID-19/cancer field by @CharuAggarwalMD: two of the studies are freely available https:/…
Thoughtful discussion of state of the COVID-19/cancer field by @CharuAggarwalMD: two of the studies are freely available https://t.co/2RL9R0F9Ij and https://t.co/ouY5OoQCpD
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/enSLlL2TPt #AACRCov
RT @KrissyMD3: @zev_dr @chrismartenson @veryvirology be sure to check out the lengthy “Disclosure of Potential Conflicts of Interest” secti…
RT @KrissyMD3: @zev_dr @chrismartenson @veryvirology be sure to check out the lengthy “Disclosure of Potential Conflicts of Interest” secti…
@zev_dr @chrismartenson @veryvirology be sure to check out the lengthy “Disclosure of Potential Conflicts of Interest” section. 😑
@Scintigraphiste @BolkonskyAA @DeBunKerEtoiles @joex92_ Autre erreur. Fiolet et al. rapportent le RR de Rivera comme étant celui associé à HCQ+AZI. Mais ce RR (qui en fait un OR) est celui "HCQ + any other therapy" Vous pouvez vérifier, le lien est là: htt
New publication by Dr. Christopher Friese: "Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study" Read more here: https://t.co/UlDVRZhESZ
@Laura1S2 @Skyrandar @takeheight7 @aragon_jb Allez un peu de lecture. Une parmi plus de 80 études favorables. Avec des patients cancéreux. Mortalité divisée par 2.5 : https://t.co/SXgKjrtG9C
RT @COVID19nCCC: Utilization of #COVID19 Tx & clinical outcomes among patients w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort st…
RT @COVID19nCCC: Utilization of #COVID19 Tx & clinical outcomes among patients w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort st…
RT @COVID19nCCC: Utilization of #COVID19 Tx & clinical outcomes among patients w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort st…
RT @COVID19nCCC: Utilization of #COVID19 Tx & clinical outcomes among patients w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort st…
RT @COVID19nCCC: Utilization of #COVID19 Tx & clinical outcomes among patients w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort st…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 Tx & clinical outcomes among patients w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort st…
RT @COVID19nCCC: Utilization of #COVID19 Tx & clinical outcomes among patients w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort st…
RT @COVID19nCCC: Hydroxychloroquine + any other drug assoc w/ incr mortality --> Utilization of #COVID19 Tx & clinical outcomes among patie…
RT @COVID19nCCC: Hydroxychloroquine + any other drug assoc w/ incr mortality --> Utilization of #COVID19 Tx & clinical outcomes among patie…
RT @COVID19nCCC: Utilization of #COVID19 Tx & clinical outcomes among patients w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort st…
Utilization of #COVID19 Tx & clinical outcomes among patients w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera et al. @CD_AACR https://t.co/v7lINKLnZi #AACRCovid #COVID19nCancer Fig2 Heatmap of selected clinical
Hydroxychloroquine + any other drug assoc w/ incr mortality --> Utilization of #COVID19 Tx & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera et al. @CD_AACR https://t.co/v7
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/v7lINKLnZi #AACRCov
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
Great research collaboration including our own @orpanag @BrownHSPP @Brown_SPH
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
Utilization of #COVID19 Tx & clinical outcomes among patients w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera et al. @CD_AACR https://t.co/v7lINKLnZi #AACRCovid #COVID19nCancer Fig2 Heatmap of selected clinical
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/v7lINKLnZi #AACRCov
@YrielPenguin @PierreProt @T_Fiolet @solatges2 Donc le poids de 0.8 utilisé pour l'ajustement n'a aucune raison de favoriser le groupe HCQ. dans Arshad. Et pour le fun, à coté de ça, ils ont gardé Rivera, qui attribue un RR de 2.8 aux corticosteroïdes 5/n
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/enSLlL2TPt #AACRCov
RT @CD_AACR: Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer. @COVID19nCCC @hemoncwarner #COVID19nCan…
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer. @COVID19nCCC @hemoncwarner #COVID19nCancer #AACRCovid #ESMO20 https://t.co/7Fu9gjau7y https://t.co/Y6NKeUviCY
.@BrownGero @BrownHSPP researcher @orpanag addressing a crucial need to discover, repurpose safe & effective treatments to mitigate the severity & mortality of COVID-19, especially true for cancer patients. @BrownUResearch @Brown_SPH https://t.co/b
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/enSLlL2TPt #AACRCov
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study | Cancer Discovery https://t.co/rsPB9mDvYf
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study https://t.co/dxXYT3yGLR